In the last trading session, 0.26 million shares of the Theratechnologies Inc (NASDAQ:THTX) were traded, and its beta was 1.07. Most recently the company’s share price was $1.54, and it changed around -$0.03 or -1.91% from the last close, which brings the market valuation of the company to $37.27M. THTX currently trades at a discount to its 52-week high of $2.18, offering almost -41.56% off that amount. The share price’s 52-week low was $1.08, which indicates that the current value has risen by an impressive 29.87% since then. We note from Theratechnologies Inc’s average daily trading volume that its 10-day average is 0.31 million shares, with the 3-month average coming to 116.38K.
Theratechnologies Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended THTX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Theratechnologies Inc is expected to report earnings per share of 0 for the current quarter.
Theratechnologies Inc (NASDAQ:THTX) trade information
Instantly THTX has showed a red trend with a performance of -1.91% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.6600 on recent trading dayincreased the stock’s daily price by 7.23%. The company’s shares are currently down -14.92% year-to-date, but still down -2.53% over the last five days. On the other hand, Theratechnologies Inc (NASDAQ:THTX) is -16.98% down in the 30-day period. We can see from the shorts that 48503.0 shares have been sold at a short interest cover period of 0.42 day(s).
Theratechnologies Inc (THTX) estimates and forecasts
The year-over-year growth rate is expected to be 2.77%, up from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 29.38M in revenue for the current quarter. 2 analysts expect Theratechnologies Inc to make 28.21M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 22.08M and 30.05M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 33.06%. Forecasts for the next quarter put sales growth at -6.11%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 23.68%.
THTX Dividends
Theratechnologies Inc’s next quarterly earnings report is expected to be released on 2025-Feb-25.
Theratechnologies Inc (NASDAQ:THTX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.15% of Theratechnologies Inc shares, and 50.11% of them are in the hands of institutional investors. The stock currently has a share float of 50.69%. Theratechnologies Inc stock is held by 50.0 institutions, with MAI CAPITAL MANAGEMENT being the largest institutional investor. By 2024-06-30, it held 0.0636% of the shares, which is about 29242.0 shares worth $40939.0.
The former held 25.68 shares worth $39548.0, making up 0.06% of all outstanding shares.
